DIVIS LABORATORIES Announces Quarterly Results (3QFY20); Net Profit Down 4.9%
Thu, 6 Feb

DIVIS LABORATORIES has announced its results for the quarter ended December 2019. Here is a detailed performance review of the same:

DIVIS LABORATORIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-18*
3
Sep-19*
3
Dec-19*
QoQ ChangeYoY Change
Net SalesRs m13,42914,45613,905-3.8%3.5%
Other incomeRs m346470403-14.3%16.6%
TurnoverRs m13,77514,92614,308-4.1%3.9%
ExpensesRs m8,1969,5508,936-6.4%9.0%
Gross profitRs m5,2334,9064,9691.3%-5.1%
DepreciationRs m4254594671.7%9.9%
InterestRs m253816-59.1%-38.5%
Profit before taxRs m5,1294,8794,8890.2%-4.7%
TaxRs m1,3341,3111,282-2.2%-3.9%
Profit after taxRs m3,7953,5683,6071.1%-4.9%
Gross profit margin%39.033.935.7
Effective tax rate%26.026.926.2
Net profit margin%27.523.925.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 3.5% on a year-on-year (YoY) basis. The expenses were up by 9.0% YoY during the same period.
  • The company's operating profit declined by 5.1% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 35.7% in 3QFY20 as against 39.0% in 3QFY19.
  • Depreciation charges increased by 9.9% and finance costs declined by 38.5% YoY, respectively.
  • Other income increased by 16.6% YoY during the quarter.
  • Net profit for the quarter declined by 4.9% YoY. Net profit margins during the quarter declined from 27.5% in 3QFY19 to 25.2% in 3QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 3.8% on a quarter-on-quarter (QoQ) basis. The expenses were down by 6.4% QoQ during the same period.
  • The company's operating profit increased by 1.3% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 35.7% in 3QFY20 as against 33.9% in 2QFY19.
  • Net profit for the quarter increased by 1.1% QoQ, while net profit margins increased from 23.9% in 2QFY19 to 25.2% in 3QFY20.

To see how DIVIS LABORATORIES has performed over the last eight quarters,please visit here.

FREE Subscription: Join Our YouTube Channel Today

DIVIS LABORATORIES Share Price Performance

Over the last one year,DIVIS LABORATORIES share price has moved up from Rs 1,654.1 to Rs 2,049.8, registering a Gain of Rs 395.7 or around 23.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,040.5 (up 0.7%). Over the last one year it has moved up from 13,863.1 to 14,040.5, a gain of 177 points (up 1.3%).

Overall, the S&P BSE SENSEX is up 12.4% over the year.

Current Valuations

At the current price of Rs 2,049.8, the price to earnings (P/E) ratio of DIVIS LABORATORIES stands at 42.7 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 7.8 times.